dr. eric winer on carboplatin and/or bevacizumab in triple-negative breast cancer
Published 8 years ago • 377 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
2:07
dr. eric p. winer on pathologic complete response and disease free survival in breast cancer
-
1:45
dr. sikov on bevacizumab or carboplatin impact on tnbc subtype
-
7:40
study of carboplatin plus nivolumab in metastatic triple-negative breast cancer
-
1:24
meet breast cancer specialist eric winer, md
-
22:54
testing, treating, and targeting triple negative breast cancer | 2023 west oncology conference
-
37:43
solchan won: bacterial evs in cancer immunotherapy
-
18:38
how to treat triple negative breast cancer | dr. ruth o'regan chair & dr. anna weiss
-
2:29
triple negative breast cancer - pathology results!!
-
4:26
late stage breast cancer: treatable? | triple negative | prof yip cheng har & dr nur fadhlina
-
1:34
debate over breast cancer drug
-
1:27
what to do in patients with early-stage tnbc who have not achieved a pcr?
-
13:10
eric p. winer, md: endocrine therapy for breast cancer - looking into the future
-
1:18
dr. overmoyer on inflammatory triple negative breast cance
-
2:26
case 3: metastatic triple-negative breast cancer
-
1:46
know about tnbc (triple negative breast cancer)- dr. suresh babu m c | samrohana | doctors' circle
-
28:03
triple negative breast cancer - o'regan
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer
-
8:08
parp inhibitors and carboplatin for neoadjuvant triple negative breast cancer treatment
-
18:29
new frontiers in triple negative breast cancer
-
0:42
triple negative breast cancer foundation
-
33:30
neelima denduluri, md -- treatment of triple negative breast cancer
-
5:47
triple negative breast cancer update